Paul V. Maier, Director at International Stem Cell CORP (ISCO.OB), sold 20,000 shares at $1.71 ($38K) on 2010-12-16, disclosed to the SEC on 2010-12-17.
Scheduled sale ($38k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.71 | 10,000 | $17K | 45.1% |
| 2 | $2.08 | 10,000 | $21K | 54.9% |
| Total | $1.90 avg | 20,000 | $38K | 100% |
| Filing → |
| ETON | BUY | 2018-11-15 | $30K | — | Filing → |
| MBVX | SELL | 2018-01-24 | $30K | — | Filing → |
| MBVX | BUY | 2015-06-02 | $12K | — | Filing → |